Skip to main content

Archives

News

New potential therapy for Crohn’s disease in children

Posted: February 24 2021

Scientists from the Stanley Manne Children’s Research Institute at Ann & Robert H. Lurie Children’s Hospital of Chicago demonstrated that a nanotherapy reduces intestinal inflammation and shrinks lesions in a rodent model of severe Crohn’s disease. This approach could become an alternative to biologic antibody therapies that carry many side effects, including increased risk of certain cancers. […]

Read more

Blog

I’m a nutritionist with IBD. These are my 5 favorite foods for gut health

Posted: February 18 2021

By Alexa Federico While there’s not a singular list of foods that everyone with IBD should toss in their grocery carts (food tolerances vary across the board), there are a handful of foods that stand out as my personal favorites for great gut health. Bone broth Bone broth is a food with ancient origins. It’s made by […]

Read more

News

Fungi in the gut prime immunity against infection

Posted: February 12 2021

Common fungi, often present in the gut, teach the immune system how to respond to their more dangerous relatives, according to new research from scientists at Weill Cornell Medicine. Breakdowns in this process can leave people susceptible to deadly fungal infections. The study, published Feb. 5 in Cell, reveals a new twist in the complex relationship […]

Read more

News

Study identifies ‘Achilles heel’ of bacteria linked to Crohn’s disease

Posted: February 11 2021

In a study published Feb. 3 in Cell Host and Microbe, the investigators showed that patients with Crohn’s disease have an overabundance of a type of gut bacteria called adherent-invasive Escherichia coli (AIEC), whichpromotes inflammation in the intestine. Their experiments revealed that a metabolite produced by the bacteria interacts with immune system cells in the lining of […]

Read more

News

Scientists switch on tissue repair in inflammatory bowel disease

Posted: February 9 2021

When functioning correctly, the immune system protects against harmful agents such as bacteria that get into the body. But in conditions such as inflammatory bowel disease (IBD), the immune system attacks the tissues that line the gut, forming ulcers and causing pain and discomfort. Nearly 3.9 million women and 3.0 million men are living with […]

Read more

Blog

Why spending time around other living things positively affects your health

Posted: February 9 2021

By Markham Heid. How our environments rub off on us, sometimes literally Since 1989, when an American immunologist named David Strachan first introduced it, the “hygiene hypothesis” has gained attention and momentum. In its original form, the hypothesis held that early childhood exposure to germs — meaning infection- or illness-causing microbes — could protect people from […]

Read more

Research

International perspectives on management of inflammatory bowel disease

Opinion differences and similarities between patients and physicians from the IBD GAPPS Survey.

Abstract Background Inflammatory bowel diseases (IBD), including Crohn disease (CD) and ulcerative colitis (UC), are complex disorders with multiple comorbidities. We conducted international patient and physician surveys to evaluate current experiences and perceptions of patients with CD or UC and physicians who treat IBD. Methods The IBD Global Assessment of Patient and Physician Unmet Need […]

Read more

News

‘Creeping Fat’ in Crohn’s patients linked to bacteria

Posted: February 5 2021

In many patients with Crohn’s disease abdominal fat migrates to the wall of the inflamed small intestines. What prompts the fat tissue to “creep” through the abdomen and wrap around the intestines of many patients with this inflammatory bowel disease (IBD) has been an enduring mystery. Now, investigators have identified a critical clue. In a study […]

Read more

Research

Opening a new door into kinder, gentler therapies for chronic inflammation

A naturally occurring antibody capable of stimulating the body's immune-suppressing regulatory T cells has been discovered by a team of Harvard scientists.

Biologic treatments that have been developed over the past quarter-century have proved to be game-changers, but the drugs are imperfect and leave some patients vulnerable to opportunistic infections, and in rare instances, cancers of the blood. Clearly, there is room for improvement, immunologists worldwide contend. The newly identified antibody is noteworthy because of its activity […]

Read more

News

First-line treatment with infliximab versus conventional treatment

Posted: January 31 2021

Abstract Objective In newly diagnosed paediatric patients with moderate-to-severe Crohn’s disease (CD), infliximab (IFX) is initiated once exclusive enteral nutrition (EEN), corticosteroid and immunomodulator therapies have failed. We aimed to investigate whether starting first-line IFX (FL-IFX) is more effective to achieve and maintain remission than conventional treatment. Design In this multicentre open-label randomised controlled trial, untreated patients […]

Read more